Pan Cancer T secures €4.25 Million in a Seed Extension round led by InnovationQuarter to advance next-generation T cell therapies
Amount Raised
€4.25 Million
Round Type
Seed
RotterdamBiotechnologyHealth CareInvestors
Description
Pan Cancer T has successfully closed a €4.25 million Seed Extension round, including a new investor InnovationQuarter and continued support from existing investors. The funding will allow the company to complete preclinical studies for its lead TCR-T cell product, progress CMC activities, and support progression of earlier-stage pipeline projects targeting colorectal and ovarian cancers.
Quick answer
Pan Cancer T raised €4.25 Million in a Seed round, dated July 11, 2024. Investors: Erasmus Mc O&O Holdings, Swanbridge Capital, Thuja Capital, Van Herk Ventures and Innovation Quarter. Pan Cancer T is based in Rotterdam, South Holland, Netherlands.
- How much did Pan Cancer T raise?
- Pan Cancer T raised €4.25 Million in a Seed round on July 11, 2024.
- Who invested in Pan Cancer T?
- Erasmus Mc O&O Holdings, Swanbridge Capital, Thuja Capital, Van Herk Ventures and Innovation Quarter are named as investors in this round.
- What does Pan Cancer T do?
- Pan Cancer T is a biotechnology spin-out (Erasmus MC, Rotterdam) focussed on the discovery and development of T cell receptor (TCR) T cell therapies.
- Where is Pan Cancer T based and how big is it?
- Pan Cancer T is based in Rotterdam, South Holland, Netherlands. Fundz records about 8 employees.
- Who are the decision-makers at Pan Cancer T?
- Fundz holds 2 contacts at Pan Cancer T, including the Founder. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Pan Cancer T that raised within 45 days of this round, from Fundz verified event records.
- XO Life raised $7.8M on August 23, 2024.
- Navigator Medicines raised $50M on August 23, 2024.
- Borealis Biosciences raised $150M (Series A) on August 22, 2024.
- Openwater raised $100M (Funding Round) on August 22, 2024.
- NADMED raised $3.5M (Series A) on August 22, 2024.
- Bond Biosciences raised $2.6M (Seed) on August 22, 2024.
Who to call at Pan Cancer T, and when
A new round usually means Pan Cancer T is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Pan Cancer T raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Pan Cancer T, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Pan Cancer T. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Pan Cancer T raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Pan Cancer T raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.